Fetal and perinatal outcomes in type 1 diabetes pregnancy: a randomized study comparing insulin aspart with human insulin in 322 subjects

被引:114
作者
Hod, Moshe [1 ]
Damm, Peter [2 ]
Kaaja, Risto [3 ]
Visser, Gerard H. A. [4 ]
Dunne, Fidelma [5 ]
Demidova, Irina [6 ]
Hansen, Anne-Sofie Pade [7 ]
Mersebach, Henriette [7 ]
机构
[1] Tel Aviv Univ, Helen Schneider Hosp Women, Sackler Fac Med, Rabin Med Ctr,Perinatal Div, IL-49100 Petah Tiqwa, Israel
[2] Univ Copenhagen Hosp, Rigshosp, Dept Obstet, Ctr Pregnant Women Diabet, Copenhagen, Denmark
[3] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland
[4] Univ Med Ctr, Dept Obstet, Utrecht, Netherlands
[5] Med Hlth Sci, Galway, Ireland
[6] City Hosp 1, Moscow, Russia
[7] Novo Nordisk AS, Modern Insulin, Global Dev, Bagsvaerd, Denmark
关键词
human insulin; insulin aspart; perinatal outcomes; pregnancy; type; 1; diabetes; GLYCEMIC CONTROL; PRETERM DELIVERY; DOUBLE-BLIND; WOMEN; MORTALITY; MELLITUS; TRIAL; NATIONWIDE;
D O I
10.1016/j.ajog.2007.08.005
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: The objective of the study was a comparison of insulin aspart (IAsp) with human insulin (HI) in basal-bolus therapy with neutral protamine Hagedorn for fetal and perinatal outcomes of type 1 diabetes in pregnancy. STUDY DESIGN: This was a randomized, parallel, open-label, controlled, multicenter, multinational study. Subjects were pregnant (gestational age; < 10 weeks) or planning pregnancy at enrollment. Three hundred twenty-two women with type 1 diabetes received IAsp (n = 157) or HI (n = 165). RESULTS: For IAsp and HI, respectively, there were 137 and 131 live births and 14 and 21 fetal losses. Perinatal mortality was 14 and 22 per 1000 births; number of congenital malformations were 6 and 9; mean (SEM) birthweight corrected for gestational age was 3438 g (71.5) and 3555 g (72.9; P = .091). Mean gestational age was 37.6 vs 37.4 weeks. Preterm delivery occurred in 20.3% (IAsp) and 30.6% (HI) of pregnancies (P = .053). CONCLUSION: The fetal outcome using IAsp was comparable with HI with a tendency toward fewer fetal losses and preterm deliveries.
引用
收藏
页码:186.e1 / 186.e7
页数:7
相关论文
共 27 条
[1]  
Alawi H, 2001, DIABETES, V50, pA381
[2]  
American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS76
[3]  
[Anonymous], COCHRANE DATABASE SY
[4]   Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study [J].
Casson, IF ;
Clarke, CA ;
Howard, CV ;
McKendrick, O ;
Pennycook, S ;
Pharoah, POD ;
Platt, MJ ;
Stanisstreet, M ;
vanVelszen, D ;
Walkinshaw, S .
BRITISH MEDICAL JOURNAL, 1997, 315 (7103) :275-278
[5]  
Diabet Control Complications Trial Res Grp, 1996, AM J OBSTET GYNECOL, V174, P1343
[6]   Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands [J].
Evers, IN ;
de Valk, HW ;
Visser, GHA .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7445) :915-918A
[7]  
Garg Satish K, 2003, Endocr Pract, V9, P187
[8]   Prospective population based survey of outcome of pregnancy in diabetic women: results of the northern diabetic pregnancy audit, 1994 [J].
Hawthorne, G ;
Robson, S ;
Ryall, EA ;
Sen, D ;
Roberts, SH ;
Platt, MPW .
BRITISH MEDICAL JOURNAL, 1997, 315 (7103) :279-281
[9]   Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes [J].
Heller, SR ;
Colagiuri, S ;
Vaaler, S ;
Wolffenbuttel, BHR ;
Koelendorf, K ;
Friberg, HH ;
Windfeld, K ;
Lindholm, A .
DIABETIC MEDICINE, 2004, 21 (07) :769-775
[10]   Insulin aspart vs. human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial [J].
Home, PD ;
Lindholm, A ;
Riis, A .
DIABETIC MEDICINE, 2000, 17 (11) :762-770